Fresenius Medical Care AG & Co. KGaA (FME) PT Set at €100.00 by Kepler Capital Markets

Kepler Capital Markets set a €100.00 ($123.46) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note published on Friday morning. The brokerage currently has a buy rating on the stock.

A number of other analysts also recently issued reports on the stock. Barclays set a €90.00 ($111.11) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Friday, March 9th. Commerzbank set a €82.00 ($101.23) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Thursday, March 8th. Berenberg Bank set a €101.00 ($124.69) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Monday, March 5th. Nord/LB set a €102.00 ($125.93) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Wednesday, February 28th. Finally, Cfra set a €97.00 ($119.75) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Wednesday, February 28th. Ten equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of €92.50 ($114.20).

How to Become a New Pot Stock Millionaire

Fresenius Medical Care AG & Co. KGaA (ETR:FME) traded down €1.20 ($1.48) during midday trading on Friday, reaching €81.96 ($101.19). 1,231,671 shares of the company’s stock were exchanged, compared to its average volume of 704,197. The company has a market cap of $25,250.00 and a P/E ratio of 19.61. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €75.53 ($93.25) and a 52-week high of €93.82 ($115.83).

COPYRIGHT VIOLATION WARNING: This article was first published by Transcript Daily and is owned by of Transcript Daily. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://transcriptdaily.com/2018/03/17/fresenius-medical-care-ag-100-00-by-kepler-capital-markets.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply